NCT06825416View on ClinicalTrials.gov

Phase III Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,167

Participants

Timeline

Start Date

March 14, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Prevention of Arterial and Venous Thrombosis
Interventions
DRUG

SHR-2004 injection

SHR-2004 injection in low dose.

DRUG

SHR-2004 injection

SHR-2004 injection in high dose.

DRUG

Enoxaparin sodium injection

Enoxaparin sodium injection.

DRUG

Enoxaparin sodium injection placebo

Enoxaparin sodium injection placebo.

DRUG

SHR-2004 placebo

SHR-2004 placebo in low dose.

DRUG

SHR-2004 placebo

SHR-2004 placebo in high dose.

Trial Locations (2)

100048

RECRUITING

Fourth Medical Center of Chinese People's Liberation Army General Hospital, Beijing

410008

RECRUITING

Xiangya Hospital, Central South University, Changsha

All Listed Sponsors
lead

Beijing Suncadia Pharmaceuticals Co., Ltd

INDUSTRY